We have identified a series of heterozygous missense mutations in TUBB3, encoding the neuron-specific beta-tubulin isotype III, that result in a spectrum of human nervous system disorders we now call the TUBB3 syndromes. Each mutation causes the ocular motility disorder CFEOM3, whereas some also result in intellectual and behavioral impairments, facial paralysis, and/or later-onset axonal sensorimotor polyneuropathy. Neuroimaging reveals a spectrum of abnormalities including hypoplasia of oculomotor nerves, and dysgenesis of the corpus callosum, anterior commissure, and corticospinal tracts. A knock-in disease mouse model reveals axon guidance defects without evidence of cortical cell migration abnormalities. We found that the disease-associated mutations can impair tubulin heterodimer formation in vitro, although folded mutant heterodimers can still polymerize into microtubules. Modeling each mutation in yeast tubulin demonstrated that all alter dynamic instability whereas a subset disrupts the interaction of microtubules with kinesin motors. These findings demonstrate that normal TUBB3 is required for axon guidance and maintenance in mammals.
Ongoing studies in the lab are aimed at better defining the clinical spectrum of the TUBB3 syndromes and the apparent genotype-phenotype correlations, and further defining the unique roles of normal and mutant Tubb3 in development and, in particular, in axon growth and guidance.
Children's Hospital press release, 1/7/10